U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Avella of Deer Valley, Inc. dba Avella - 02/03/2017
  1. Warning Letters

CLOSEOUT LETTER

Avella of Deer Valley, Inc. dba Avella


Recipient:
Avella of Deer Valley, Inc. dba Avella

United States

Issuing Office:

United States


 

  

Black HHS-Blue FDA Logo

 

 

 
Los Angeles District
19701 Fairchild Road
Los Angeles, CA 92612 

UNITED PARCEL SERVICE
SIGNATURE REQUIRED

February 3, 2017

Dr. John D. Musil, CEO/Founder
Avella of Deer Valley, Inc. dba Avella
1606 W. Whispering Wind Dr., 2nd Floor
Phoenix, AZ 85085

Dear Dr. Musil,

The Food and Drug Administration has completed an evaluation of Avella’s corrective actions in response to our warning letter (WL# 10-14, January 17, 2014) issued based on our inspectional findings at your facility located at 23620 N. 20th Drive, Suite 12, Phoenix, AZ 85085. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.

You are expected to take all necessary steps to assure compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/

CDR Steven E. Porter, Jr.
Los Angeles District Director
 

 
Back to Top